ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGY Allergy Therapeutics Plc

7.00
0.20 (2.94%)
03 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Allergy Therapeutics Plc LSE:AGY London Ordinary Share GB00B02LCQ05 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.20 2.94% 7.00 6.00 7.00 6.98 6.50 6.50 599,477 16:35:13
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 55.2M -40.22M -0.0084 -7.74 324.12M
Allergy Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AGY. The last closing price for Allergy Therapeutics was 6.80p. Over the last year, Allergy Therapeutics shares have traded in a share price range of 1.88p to 6.98p.

Allergy Therapeutics currently has 4,766,439,938 shares in issue. The market capitalisation of Allergy Therapeutics is £324.12 million. Allergy Therapeutics has a price to earnings ratio (PE ratio) of -7.74.

Allergy Therapeutics Share Discussion Threads

Showing 5126 to 5148 of 5350 messages
Chat Pages: 214  213  212  211  210  209  208  207  206  205  204  203  Older
DateSubjectAuthorDiscuss
19/9/2024
07:08
Banjo/CoinThe longer term funding must be the priority do you think?jl
jimmyloser
18/9/2024
15:38
Yes, I believe they maybe due. Perhaps next week. impo they could be the catalyst for the next step back up.
jimmyloser
18/9/2024
15:29
Are the preliminary results due in next few weeks, if so that will be very interesting!
totally banjo
18/9/2024
14:33
Plenty of potentially good news likely before then Let's hear that the cash is sortedThe market application inProgress in manufacturing and cost controlThe biomarkers are exceptional My own take is if all goes well then 7 p might be achieved.AGY need to deliver and whilst trials are going well, it is real tangible and exciting news that is needed here.Impo that is.
jimmyloser
18/9/2024
14:17
Saying that, it's not long until December so we should see interest build as we near the initial results of the PROTECT trial and if positive then you would think double figures regarding the SP, imo
totally banjo
17/9/2024
23:15
Yesterdays Cavendish coverage is basically just a repeat of the AGY update but saying that it's very positive that they appear to be working very well together in promoting the company! The initial coverage note is worth reading as it explains their view on where the company 'could' go if everything works out.

As said before in the shorter term it's what happens regarding their current product line in Europe and elsewhere after the various manufacturing improvements, which should see an increase in revenue which will have a positive effect on the share price

The products they offer are not just for the summer months as the allergies they protect from cover various causes and seasons, I assume there is a build up factor too for people with certain allergies but will have to look into that statement!

totally banjo
17/9/2024
13:25
Yes, they’re very bullish. 4.075 GBX is peanuts!
coinbase
17/9/2024
13:12
Hi CoinIt makes good reading. I see BLUE as I typeI should say that it is about timeImpo
jimmyloser
17/9/2024
11:59
Jimmy, I’ve just read it. Thanks for pointing it out.
coinbase
17/9/2024
10:02
I wasn't expecting an update on the PROTECT trial just yet so this is a bonus and great to hear that all is going to plan!
totally banjo
17/9/2024
09:22
A very upbeat note from Cavendish this morningDyor etc
jimmyloser
17/9/2024
06:54
That settles my nerves and hopefully our two key investors nerves too!I like the word 'keen' in Senor Llobets summaryThis is certainly encouraging news for those needing this product but still early days.Impo etc
jimmyloser
17/9/2024
06:31
"Blood samples taken from peanut allergic study volunteers before and after dosing in cohorts 1 and 2 are being analysed to identify key biomarker changes indicative of efficacy. Basophil activation testing (BAT) mimics an allergic reaction by stimulating basophils with peanut allergens and then observing the expression of activation markers on the surface of the basophils. A reduction in the expression of those markers in the volunteers' samples would be indicative of efficacy in the VLP Peanut vaccine candidate. The preliminary results from the first two cohorts of peanut allergic patients are expected in Q4 2024."
coinbase
13/9/2024
18:44
Jpuff,I may be wrong but from years ago those types of trades were deemed as a person moving from a normal trading account to an ISA, I'm sure someone will put me right :-)
totally banjo
13/9/2024
15:18
The trades today - similar to some seen on previous days - show blocks two or paired buys at exactly the same time. So why are two 20k buys shown and not one 40k buy as there are several instances of this so can't be coincidence of different buyers?
jpuff
12/9/2024
17:27
Yes jl, very interesting.
farmergeorge
12/9/2024
16:35
I find this very interesting..................

impo/etc.

jimmyloser
06/9/2024
18:39
Hi Banjo,
That is good work. I reckon that would qualify for being a
‘ BLOCKBUSTER’ size market by anyones reckoning, if they can pull this off.
Jl

jimmyloser
06/9/2024
16:52
Allergy Treatment Market Size and Share Projected to Surpass USD 34.9 Billion by 2034 at 5.8% CAGR - Report by Transparency Market Research, Inc.

"Lastly, Allergy Therapeutics offers subcutaneous immunotherapy and sublingual immunotherapy. These are the key working verticals for the organization."

hxxps://www.globenewswire.com/news-release/2024/09/05/2941609/0/en/Allergy-Treatment-Market-Size-and-Share-Projected-to-Surpass-USD-34-9-Billion-by-2034-at-5-8-CAGR-Report-by-Transparency-Market-Research-Inc.html


hxxps://www.transparencymarketresearch.com/allergy-treatment-market.html

totally banjo
06/9/2024
12:45
Cheap as chips Jimmy. Lots of madness in the current dysfunctional markets with AGY a good example. I'm personally looking forward to great returns here and remaining patient.
jpuff
06/9/2024
12:04
Jimmy rides to our rescue and restores common sense. The price (if you believe)is just stupid
impo/dyor et al

jimmyloser
05/9/2024
00:35
Got beat 6-3 at pool tonight :-( but I won singles and doubles games :-)

Anyway, in my opinion over the shorter term is seeing increased revenue in Europe due to their expanded manufacturing facilities to facility the demand for their existing products is key!

There is so much potential (that word again) for this company to make massive gains for existing and new shareholders regarding the results of their various trials but they will take time (years) before they are revenue generating!

If AGY issues the results of the PROTECT trial in Q4 2024 and if it's positive the share price will rocket!

As said before, very boring stock to hold but could pay huge and I mean huge dividends from this current share price in a year or three or before if they get bought out!

Do your own research as always!

totally banjo
04/9/2024
10:24
The PROTECT trial estimated completion date is a few months into 2025 but this, I believe, is the follow up on subjects after the trial is finished.

Therefore it is likely that we will get the results of the trial in Q4 2024 which will, if positive, give AGY exposure on the global stage which should be reflected in the share price

I'm very positive for AGY future but it does need highlighting that the various on going trials will take time to become revenue generating. It is also quite possible AGY could be bought out before this time!

totally banjo
Chat Pages: 214  213  212  211  210  209  208  207  206  205  204  203  Older

Your Recent History

Delayed Upgrade Clock